ImageneBio, Inc.
IMA
$5.52
-$0.04-0.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.98% | -52.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 42.04% | -68.02% | |||
| Operating Income | -42.04% | 68.02% | |||
| Income Before Tax | -47.68% | 71.09% | |||
| Income Tax Expenses | 103.62% | -272.97% | |||
| Earnings from Continuing Operations | -53.72% | 72.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.72% | 72.12% | |||
| EBIT | -42.04% | 68.02% | |||
| EBITDA | -47.69% | 69.50% | |||
| EPS Basic | -53.32% | 73.04% | |||
| Normalized Basic EPS | -47.36% | 71.09% | |||
| EPS Diluted | -53.32% | 73.04% | |||
| Normalized Diluted EPS | -47.36% | 71.09% | |||
| Average Basic Shares Outstanding | 0.27% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||